GNMSF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Genmab A/S

Watchlist Manager

Watchlist

Price: 350 USD 2.04% Market Closed

Market Cap: $22.8B

G	Genmab A/S OTC:GNMSF	DK
E	Eli Lilly and Co DUS:LLY	US
C	Citigroup Inc XMUN:TRVC	US
W	W.p. Carey Inc LSE:0LS8	US

Profitability Summary

Genmab A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

93%

Gross Margin is Increasing

45% > 93%

Exceptional Operating Margin

32%

Strong 3Y Average Operating Margin

33%

Declining Operating Margin

39% > 32%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

29%

Declining Net Margin

28% > 19%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

32%

Declining Free Cash Flow Margin

35% > 21%

Positive ROE

14%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

37%

Declining ROIC

76% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.